A business in context
CL research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-16 | Wallace Noel R. | A · Grant / award | Common Stock | 29649.0 | 0.0 |
| 2026-09-16 | Wallace Noel R. | A · Grant / award | Stock Option (Right to Buy) | 205197.0 | 0.0 |
| 2026-09-16 | GRANT SHANE | A · Grant / award | Common Stock | 7355.0 | 0.0 |
| 2026-09-16 | GRANT SHANE | A · Grant / award | Stock Option (Right to Buy) | 50902.0 | 0.0 |
| 2026-09-16 | Tsourapas Panagiotis | A · Grant / award | Common Stock | 4597.0 | 0.0 |
| 2026-09-16 | Tsourapas Panagiotis | A · Grant / award | Stock Option (Right to Buy) | 31814.0 | 0.0 |
| 2026-09-16 | SUTULA STANLEY J III | A · Grant / award | Common Stock | 8045.0 | 0.0 |
| 2026-09-16 | SUTULA STANLEY J III | A · Grant / award | Stock Option (Right to Buy) | 55674.0 | 0.0 |
| 2026-09-16 | Hazlin John | A · Grant / award | Common Stock | 3908.0 | 0.0 |
| 2026-09-16 | Hazlin John | A · Grant / award | Stock Option (Right to Buy) | 27042.0 | 0.0 |
| 2026-09-16 | Massey Sally | A · Grant / award | Common Stock | 3333.0 | 0.0 |
| 2026-09-16 | Massey Sally | A · Grant / award | Stock Option (Right to Buy) | 23065.0 | 0.0 |
| 2026-09-16 | Fishbone Betsy | A · Grant / award | Common Stock | 2207.0 | 0.0 |
| 2026-09-16 | Fishbone Betsy | A · Grant / award | Stock Option (Right to Buy) | 15271.0 | 0.0 |
| 2026-09-16 | Malcolm Gregory | A · Grant / award | Common Stock | 1081.0 | 0.0 |
| 2026-09-16 | Malcolm Gregory | A · Grant / award | Stock Option (Right to Buy) | 7477.0 | 0.0 |
| 2026-09-13 | Wallace Noel R. | F · Tax / exercise payment | Common Stock | 4892.0 | 86.8 |
| 2026-09-13 | Tsourapas Panagiotis | F · Tax / exercise payment | Common Stock | 922.0 | 86.8 |
| 2026-09-13 | SUTULA STANLEY J III | F · Tax / exercise payment | Common Stock | 1385.0 | 86.8 |
| 2026-09-13 | Massey Sally | F · Tax / exercise payment | Common Stock | 686.0 | 86.8 |
| 2026-09-13 | Malcolm Gregory | F · Tax / exercise payment | Common Stock | 225.0 | 86.8 |
| 2026-09-13 | Hazlin John | F · Tax / exercise payment | Common Stock | 499.0 | 86.8 |
| 2026-09-13 | Fishbone Betsy | F · Tax / exercise payment | Common Stock | 472.0 | 86.8 |
| 2026-09-12 | Wallace Noel R. | F · Tax / exercise payment | Common Stock | 3516.0 | 86.8 |
| 2026-09-12 | Tsourapas Panagiotis | F · Tax / exercise payment | Common Stock | 618.0 | 86.8 |
| 2026-09-12 | SUTULA STANLEY J III | F · Tax / exercise payment | Common Stock | 927.0 | 86.8 |
| 2026-09-12 | Massey Sally | F · Tax / exercise payment | Common Stock | 459.0 | 86.8 |
| 2026-09-12 | Malcolm Gregory | F · Tax / exercise payment | Common Stock | 151.0 | 86.8 |
| 2026-09-12 | Hazlin John | F · Tax / exercise payment | Common Stock | 439.0 | 86.8 |
| 2026-09-12 | Fishbone Betsy | F · Tax / exercise payment | Common Stock | 331.0 | 86.8 |
| 2026-09-11 | Wallace Noel R. | F · Tax / exercise payment | Common Stock | 4071.0 | 86.8 |
| 2026-09-11 | Tsourapas Panagiotis | F · Tax / exercise payment | Common Stock | 684.0 | 86.8 |
| 2026-09-11 | SUTULA STANLEY J III | F · Tax / exercise payment | Common Stock | 1197.0 | 86.8 |
| 2026-09-11 | Massey Sally | F · Tax / exercise payment | Common Stock | 651.0 | 86.8 |
| 2026-09-11 | Malcolm Gregory | F · Tax / exercise payment | Common Stock | 167.0 | 86.8 |
| 2026-09-11 | Hazlin John | F · Tax / exercise payment | Common Stock | 649.0 | 86.8 |
| 2026-09-11 | GRANT SHANE | F · Tax / exercise payment | Common Stock | 622.0 | 86.8 |
| 2026-09-11 | Fishbone Betsy | F · Tax / exercise payment | Common Stock | 404.0 | 86.8 |
| 2026-08-24 | Tsourapas Panagiotis | S · Sale | Common Stock | 10000.0 | 92.05 |
| 2026-08-06 | CAHILL JOHN T | M · Exercise / conversion | Common Stock | 4170.0 | 71.56 |
| 2026-08-06 | CAHILL JOHN T | S · Sale | Common Stock | 4170.0 | 93.37 |
| 2026-08-06 | CAHILL JOHN T | M · Exercise / conversion | Stock Option (Right to Buy) | 4170.0 | 0.0 |
| 2026-08-05 | Wallace Noel R. | M · Exercise / conversion | Common Stock | 161021.0 | 72.29 |
| 2026-08-05 | Wallace Noel R. | S · Sale | Common Stock | 161021.0 | 92.52 |
| 2026-08-05 | Wallace Noel R. | M · Exercise / conversion | Stock Option (Right to Buy) | 161021.0 | 0.0 |
| 2026-08-04 | Wallace Noel R. | M · Exercise / conversion | Common Stock | 161021.0 | 72.29 |
| 2026-08-04 | Wallace Noel R. | S · Sale | Common Stock | 161021.0 | 91.92 |
| 2026-08-04 | Wallace Noel R. | M · Exercise / conversion | Stock Option (Right to Buy) | 161021.0 | 0.0 |
| 2026-07-01 | NORRINGTON LORRIE M | A · Grant / award | Common Stock | 293.0 | 89.45 |
| 2026-07-01 | Newman Brian | A · Grant / award | Common Stock | 209.0 | 89.45 |
Identity & relationships
SEC issuer · 0000021665COLGATE PALMOLIVE CO
Colgate-Palmolive (Switzerland)Hill's Pet NutritionHill's Pet Nutrition Manufacturing
- Legal Entity Identifier
- YMEGZFW4SBUSS5BQXF88
- GLEIF legal name
- COLGATE-PALMOLIVE COMPANY
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2025-11-10T17:17:14Z
Search names and former names
View Wikidata identity and references ↗
- Colgate-Palmolive Company · alias · wikidata
- Colgate Palmolive · alias · wikidata
- Colgate-Palmolive · alias · wikidata
- Colgate-Palmolive-Peet · alias · wikidata
- Colgate & Co · alias · wikidata
- Colgate-Palmolive (Switzerland) · subsidiary · wikidata
- Hill's Pet Nutrition · subsidiary · wikidata
- Hill's Pet Nutrition Manufacturing · subsidiary · wikidata
- Hill's Pet Nutrition Manufacturing, s.r.o. · subsidiary · wikidata
- COLGATE PALMOLIVE CO · former SEC name · 1994-05-18 to 2026-10-02
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $20.10B | $21.59B |
| 2023-12-31 | $19.46B | $21.51B |
| 2022-12-31 | $17.97B | $20.68B |
| 2021-12-31 | $17.42B | $21.66B |
| 2020-12-31 | $16.47B | $21.44B |
| 2019-12-31 | $15.69B | $20.68B |
| 2018-12-31 | $15.54B | $20.86B |
| 2017-12-31 | $15.45B | $21.24B |